Described herein are pharmaceutical packaging systems which avoid oxidative degradation of morphine, hydromorphone, promethazine along with other oxygen-delicate drugs, these techniques including a syringe with an oxygen permeable suggestion cap, a hermetically sealed oxygen barrier blister packaging with really lower permeability to oxygen and com